Taxane Response In Prostate Cancer May Not Be Influenced By Androgen Receptor Variations

Taxane response in prostate cancer may not be influenced by androgen receptor variations

Dr. Antonarakis Discusses AR-V7 and Response to Taxanes in Men With mCRPC

Androgens, Hormonal Therapy & Response in Prostate Cancer - Summit 2021

ZERO Prostate Cancer

Dr. Tagawa on Next Steps for Taxanes in Prostate Cancer

Antonarakis: AR-V7, Taxane Response in mCRPC

Cancer Therapy Advisor

Update on Mechanisms of Resistance in Castration-Resistant Prostate Cancer

Grand Rounds in Urology

Testosterone and Prostate Cancer: Is There a Link?

Grand Rounds in Urology

Andrew Armstrong, MD, explains whether ARV-7 is predictive of response to taxanes in mPC patients

Metastatic Prostate Cancer: Androgen Receptor Biology

Elahe Mostaghel - Resistance to AR Signaling Inhibitors in Castration Resistant Prostate Cancer

Dr. Agarwal on Androgen Receptor Inhibitors for Prostate Cancer

Androgen Receptor Splice Variant, AR-V7, as Prostate Cancer Biomarker

Predictors of ADT Response In Advanced Prostate Cancer.

Mayo Proceedings

Targeting AR in Castration Resistant Prostate Cancer

Grand Rounds in Urology

Management of Advanced Hormone-sensitive and Castration-resistant Prostate Cancer

Exploring the Complexities of Androgen Signaling in Prostate Cancer Progression - Eleni Efstathiou

The Society for Translational Oncology

#short #ProstateCancer #CancerResearch Alternatives for advanced prostate cancer treatment.

Dr. Geo Prostate Podcast

Dr. Higano on the Toxicity of Androgen Receptor Inhibitors in CRPC

Androgen Receptor Antagonists - Dana Rathkopf, MD

The Society for Translational Oncology

Novel Therapies for Castration-Resistant Prostate Cancer